Geron
GERN
#5870
Rank
NZ$1.86 B
Marketcap
NZ$2.91
Share price
0.00%
Change (1 day)
5.78%
Change (1 year)

Geron (GERN) - Net assets

Net assets on the balance sheet as of December 2025 : NZ$0.39 Billion

According to Geron's latest financial reports the company has NZ$0.39 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Geron - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$NZ$0.39 B-21.54%
2024-12-31$NZ$0.49 B26.77%
2023-12-31$NZ$0.39 B211.17%
2022-12-31$NZ$0.12 B-31.92%
2021-12-31$NZ$0.18 B-36.69%
2020-12-31$NZ$0.29 B45.68%
2019-12-31$NZ$0.20 B-24.26%
2018-12-31$NZ$0.26 B81.3%
2017-12-31$NZ$0.14 B-17.28%
2016-12-31$NZ$0.17 B-14.92%
2015-12-31$NZ$0.20 B24.48%
2014-12-31$NZ$0.16 B129.42%
2013-12-31$NZ$72.71 M-30.16%
2012-12-31$NZ$0.10 B-44.57%
2011-12-31$NZ$0.18 B-24.81%
2010-12-31$NZ$0.24 B5.14%
2009-12-31$NZ$0.23 B-18.15%
2008-12-31$NZ$0.29 B8.11%
2007-12-31$NZ$0.26 B8.77%
2006-12-31$NZ$0.24 B-3.96%
2005-12-31$NZ$0.25 B50.27%
2004-12-31$NZ$0.17 B4.59%
2003-12-31$NZ$0.16 B187.82%
2002-12-31$NZ$56.82 M-61.66%
2001-12-31$NZ$0.14 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
NZ$39.60 B 9,913.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$9.04 B 2,187.79%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-NZ$44.39 Million-111.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$3.52 B 790.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ$6.25 M-98.42%๐Ÿ‡บ๐Ÿ‡ธ USA